Bloomage BioTechnology Corporation Limited (SHA:688363)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Manufacturing	5.37B	6.08B	6.36B	4.95B	2.63B
Pharmaceutical Manufacturing Growth	-11.61%	-4.45%	28.53%	87.93%	-
Total	5.37B	6.08B	6.36B	4.95B	2.63B
Total Growth	-11.61%	-4.45%	28.53%	87.93%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Mainland China	6.65B	7.56B	8.57B	6.46B	3.39B
Mainland China Growth	-12.03%	-11.80%	32.50%	90.80%	-
Other Countries or Regions	366.16M	420.91M	361.49M	579.43M	403.02M
Other Countries or Regions Growth	-13.01%	16.44%	-37.61%	43.77%	-
Offset	-1.69B	-1.96B	-2.60B	-2.12B	-1.18B
Hong Kong	48.90M	54.52M	35.30M	27.96M	19.89M
Hong Kong Growth	-10.32%	54.47%	26.22%	40.62%	-98.70%
Total	5.37B	6.08B	6.36B	4.95B	2.63B
Total Growth	-11.60%	-4.46%	28.53%	87.99%	39.57%

Source: S&P Global Market Intelligence.